Lactobacillus plantarum reduces Streptococcus pyogenes virulence by modulating the IL-17, IL-23 and Toll-like receptor 2/4 expressions in human epithelial cells

International Immunopharmacology

Volumn 17, Issue 2, 2013, Pages 453-461

  Rizzo, Antonietta ^a   Losacco, Antonio ^a   Carratelli, Caterina Romano ^a   Di Domenico, Marina ^a   Bevilacqua, Nazario ^b  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b CARDARELLI HOSPITAL   (Italy)

Author keywords

Epithelial cells; IL 17; IL 23; Lactobacillus plantarum; Streptococcus pyogenes; TLR 2 4

Indexed keywords

INTERLEUKIN 17; INTERLEUKIN 23; PROBIOTIC AGENT; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4;

ARTICLE; BACTERIAL GROWTH; BACTERIAL VIRULENCE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; EPITHELIUM CELL; GROUP A STREPTOCOCCAL INFECTION; GROWTH INHIBITION; HUMAN; HUMAN CELL; INNATE IMMUNITY; LACTOBACILLUS PLANTARUM; NONHUMAN; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; STREPTOCOCCUS PYOGENES;

3-[4.5-DIMETHYL-2.5 THIAZOLYL]-2.5 DIPHENYL TETRAZOLIUM BROMIDE; A549; ABS; AMERICAN TYPE CULTURE COLLECTION; ANTIBODIES; ATCC; BH; BRAIN HEART; CDNA; CFU; COLONY-FORMING UNITS; COMPLEMENTARY DNA; ELISA; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITHELIAL CELLS; FI; FLUORESCENCE INTENSITY; GAS; GROUP A STREPTOCOCCI; HEP-2; HUMAN LARYNGEAL CARCINOMA CELL LINE; HUMAN LUNG ALVEOLAR EPITHELIAL CELL LINE; IL; IL-17; IL-23; INTERLEUKIN; LAC; LACTOBACILLUS PLANTARUM; MESSENGER RNA; MOI; MRNA; MTT; MULTIPLICITY OF INFECTION; PBS; PHOSPHATE-BUFFERED SALINE; REVERSE TRANSCRIPTASE PCR; RT-PCR; STREPTOCOCCUS PYOGENES; TBE; TLR 2/4; TLRS; TOLL-LIKE RECEPTORS; TRIS-BORATE-EDTA;

CELL LINE; EPITHELIAL CELLS; GENE EXPRESSION REGULATION; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, INNATE; INTERLEUKIN-17; INTERLEUKIN-23; LACTOBACILLUS PLANTARUM; STREPTOCOCCUS PYOGENES; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; VIRULENCE;

EID: 84881502873     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2013.07.005     Document Type: Article

References (58)

1. Reid SD, Hoe NP, Smoot LM,Musser JM. Group A Streptococcus: allelic variation, population genetics, and host-pathogen interactions. J Clin Invest 2001;107:393-9.
2. Cleary PP, Cue D. High frequency invasion of mammalian cells by beta hemolytic streptococci. Subcell Biochem 2000;33:137-66.
3. Rizzo A, Domenico MD, Carratelli CR, Paolillo R. The role of Chlamydia and Chlamydophila infections in reactive arthritis. Intern Med 2012;51:113-7.
4. Lee MS, Kim YJ. Signaling pathways downstream of pattern-recognition receptors and their cross talk. Annu Rev Biochem 2007;76:447-80.
5. Valdéz JC, Peral MC, Rachid M, Santana M, Perdigón G. Interference of Lactobacillus plantarum with Pseudomonas aeruginosa in vitro and in infected burns: the potential use of probiotics in wound treatment. Clin Microbiol Infect 2005;11:472-9. (Pubitemid 40744394)
6. Takeuchi O, Hoshino K, Kawai T, Sanjo H, Takada H, Ogawa T, et al. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity 1999;11:443-51. (Pubitemid 29504199)
7. Michelsen KS, Aicher A,MohauptM, Hartung T, Dimmeler S, Kirschning CJ, et al. The role of Toll-like receptors (TLRs) in bacteria-induced maturation ofmurine dendritic cells (DCs). Peptidoglycan and lipoteichoic acid are inducers of DC maturation and require TLR2. J Biol Chem 2001;276:25680-6.
8. Schwandner R, Dziarski R, Wesche H, Rothe M, Kirschning CJ. Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by Toll-like receptor 2. J Biol Chem 1999;274:17406-9.
9. Zhang Z, Clarke TB, Weiser JN. Cellular effectors mediating Th17-dependent clearance of pneumococcal colonization in mice. J Clin Invest 2009;119:1899-909.
10. Brauner A, Cryz SJ, Granström M, Hanson HS, Löfstrand L, Strandvik B, et al. Immunoglobulin G antibodies to Pseudomonas aeruginosa lipopolysaccharides and exotoxin A in patients with cystic fibrosis or bacteremia. Eur J Clin Microbiol Infect Dis 1993;12:430-6. (Pubitemid 23214067)
11. Caruso R, Fina D, PaoluziOA,Del Vecchio Blanco G, Stolfi C, Rizzo A, et al. IL-23-mediated regulation of IL-17 production in Helicobacter pylori-infected gastric mucosa. Eur J Immunol 2008;38:470-8.
12. Happel KI, Zheng M, Young E, Quinton LJ, Lockhart E, Ramsay AJ, et al. Cutting edge: roles of Toll-like receptor 4 and IL-23 in IL-17 expression in response to Klebsiella pneumoniae infection. J Immunol 2003;170:4432-6. (Pubitemid 36519946)
13. Vanden Eijnden S, Goriely S, De Wit D, Willems F, Goldman M. IL-23 up-regulates IL-10 and induces IL-17 synthesis by polyclonally activated naive T cells in human. Eur J Immunol 2005;35:469-75. (Pubitemid 40331324)
14. Dong C. IL-23/IL-17 biology and therapeutic considerations. J Immunotoxicol 2008;5:43-6. (Pubitemid 351431258)
15. Bengmark S. Pre-, pro- and synbiotics. Curr Opin Clin Nutr Metab Care 2001;4: 571-9. (Pubitemid 34755419)
16. Badet C, Thebaud NB. Ecology of lactobacilli in the oral cavity: a review of literature. Open Microbiol J 2008;2:38-48.
17. Alvarez S, Villena J, TohnoM, Salva S, Kitazawa H. Modulation of innate immunity by lactic acid bacteria: impact on host response to infections. Curr Res Immunol 2009;3:87-126.
18. Roselli M, Finamore A, Britti MS, Mengheri E. Probiotic bacteria Bifidobacterium animalis MB5 and Lactobacillus rhamnosus GG protect intestinal Caco-2 cells from the inflammation-associated response induced by enterotoxigenic Escherichia coli K88. Br J Nutr 2006;95:1177-84. (Pubitemid 43985998)
19. Christensen HR, Frøkiaer H, Pestka JJ. Lactobacilli differentially modulate expression of cytokines and maturation surface markers in murine dendritic cells. J Immunol 2002;168:171-8. (Pubitemid 34014116)
20. Niers LE, Timmerman HM, Rijkers GT, van Bleek GM, van Uden NO, Knol EF, et al. Identification of strong interleukin-10 inducing lactic acid bacteria which down-regulate T helper type 2 cytokines. Clin Exp Allergy 2005;35:1481-9.
21. Mack DR, Lebel S. Role of probiotics in the modulation of intestinal infections and inflammation. Curr Opin Gastroenterol 2004;20:22-6. (Pubitemid 39117953)
22. Iliev ID, Kitazawa H, Shimosato T, Katoh S, Morita H, He F, et al. Strong immunostimulation in murine immune cells by Lactobacillus rhamnosus GG DNA containing novel oligodeoxynucleotide pattern. Cell Microbiol 2005;7:403-14. (Pubitemid 40277920)
23. Abreu MT. Immunologic regulation of Toll-like receptors in gut epithelium. Curr Opin Gastroenterol 2003;19:559-64. (Pubitemid 37330475)
24. Lopes Mde F, Cunha AE, Clemente JJ, Carrondo MJ, Crespo MT. Influence of environmental factors on lipase production by Lactobacillus plantarum. Appl Microbiol Biotechnol 1999;51:249-54. (Pubitemid 29111299)
25. Marco ML, Kleerebezem M. Assessment of real-time RT-PCR for quantification of Lactobacillus plantarum gene expression during stationary phase and nutrient starvation. J Appl Microbiol 2008;104:587-94.
26. Nagy I, Pivarcsi A, Koreck A, Széll M, Urbáln E, Kemény L. Distinct strains of Propionibacterium acnes induce selective human beta-defensin-2 and interleukin-8 expression in human keratinocytes through Toll-like receptors. J Invest Dermatol 2005;124:931-8. (Pubitemid 40629093)
27. Gencay MM, Tamm M, Glanville A, Perruchoud AP, Roth M. Chlamydia pneumoniae activates epithelial cell proliferation via NF-kappaB and the glucocorticoid receptor. Infect Immun 2003;71:5814-22. (Pubitemid 37205635)
28. Bhatia SJ, Kochar N, Abraham P, Nair NG, Mehta AP. Lactobacillus acidophilus inhibits growth of Campylobacter pylori in vitro. J Clin Microbiol 1989;27:2328-30. (Pubitemid 19240622)
29. Jamalifar H, Rahimi H, Samadi N, Shahverdi A, Sharifian Z, Hosseini F, et al. Antimicrobial activity of different Lactobacillus species against multi-drug resistant clinical isolates of Pseudomonas aeruginosa. Iran J Microbiol 2011;3:21-5.
30. Paolillo R, Romano Carratelli C, Sorrentino S,Mazzola N, Rizzo A. Immunomodulatory effects of Lactobacillus plantarum on human colon cancer cells. Int Immunopharmacol 2009;9:1265-71.
31. Ng LK, Rich AM, Hussaini HM, Thomson WM, Fisher AL, Horne LS, et al. Toll-like receptor 2 is present in the microenvironment of oral squamous cell carcinoma. Br J Cancer 2011 Feb 1;104:460-3.
32. Chálvez-Sálnchez L, Madrid-Miller A, Chálvez-Rueda K, Legorreta-Haquet MV, Tesoro-Cruz E, Blanco-Favela F. Activation of TLR2 and TLR4 by minimally modified low-density lipoprotein in humanmacrophages and monocytes triggers the inflammatory response. Hum Immunol 2010;71:737-44.
33. Clarke JO, Mullin GE. A review of complementary and alternative approaches to immunomodulation. Nutr Clin Pract 2008;23:49-62. (Pubitemid 351438968)
34. Servin AL. Antagonistic activities of lactobacilli and bifidobacteria against microbial pathogens. FEMS Microbiol Rev 2004;28:405-40. (Pubitemid 39209464)
35. Cosseau C, Devine DA, Dullaghan E, Gardy JL, Chikatamarla A, Gellatly S, et al. The commensal Streptococcus salivarius K12 downregulates the innate immune responses of human epithelial cells and promotes host-microbe homeostasis. Infect Immun 2008;76:4163-75.
36. Wang S, Ng LH, Chow WL, Lee YK. Infant intestinal Enterococcus faecalis down-regulates inflammatory responses in human intestinal cell lines. World J Gastroenterol 2008;14:1067-76. (Pubitemid 351325007)
37. Shida K, Suzuki T, Kiyoshima-Shibata J, Shimada S, Nanno M. Essential roles of monocytes in stimulating human peripheral blood mononuclear cells with Lactobacillus casei to produce cytokines and augment natural killer cell activity. Clin Vaccine Immunol 2006;13:997-1003. (Pubitemid 44518967)
38. Hafez M. Interference between lactobacilli and group A Streptococcus pyogenes: an expansion to the concept of probiotics. N Engl J Med 2007;17:262-84.
39. Princivalli MS, Paoletti C, Magi G, Palmieri C, Ferrante L, Facinelli B. Lactobacillus rhamnosus GG inhibits invasion of cultured human respiratory cells by prtF1- positive macrolide-resistant group A streptococci. Lett Appl Microbiol 2009;48: 368-72.
40. Ashbaugh CD, Moser TJ, Shearer MH, White GL, Kennedy RC, Wessels MR. Bacterial determinants of persistent throat colonization and the associated immune response in a primate model of human group A streptococcal pharyngeal infection. Cell Microbiol 2000;2:283-92. (Pubitemid 30612938)
41. Leon O, Panos C. Streptococcus pyogenes clinical isolates and lipoteichoic acid. Infect Immun 1990;58:3779-87. (Pubitemid 20353383)
42. Sierig G, Cywes C,Wessels MR, Ashbaugh CD. Cytotoxic effects of streptolysin O and streptolysin S enhance the virulence of poorly encapsulated group a streptococci. Infect Immun 2003;71:446-55. (Pubitemid 36026049)
43. Draing C, Sigel S, Deininger S, Traub S, Munke R, Mayer C, et al. Cytokine induction by Gram-positive bacteria. Immunobiology 2008;213:285-96.
44. Daglia M, Papetti A, Grisoli P, Aceti C, Dacarro C, Gazzani G. Antibacterial activity of red and white wine against oral streptococci. J Agric Food Chem 2007;55: 5038-42. (Pubitemid 47056054)
45. Tien MT, Girardin SE, Regnault B, Le Bourhis L, Dillies MA, Coppee JY, et al. Antiinflammatory effect of Lactobacillus casei on Shigella-infected human intestinal epithelial cells. J Immunol 2006;176:1228-37. (Pubitemid 43099727)
46. Yan F, Polk DB. Probiotic bacterium prevents cytokine-induced apoptosis in intestinal epithelial cells. J Biol Chem 2002;277:50959-65. (Pubitemid 36042264)
47. Smits HH, van Beelen AJ, Hessle C, Westland R, de Jong E, Soeteman E, et al. Commensal Gram-negative bacteria prime human dendritic cells for enhanced IL-23 and IL-27 expression and enhanced Th1 development. Eur J Immunol 2004;34: 1371-80. (Pubitemid 39256016)
48. Verreck FA, de Boer T, Langenberg DM, Hoeve MA, Kramer M, Vaisberg E, et al. Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria. Proc Natl Acad Sci U S A 2004;101:4560-5. (Pubitemid 38437450)
49. Belladonna ML, Vacca C, Volpi C, Giampietri A, Fioretti MC, Puccetti P, et al. IL-23 neutralization protects mice from Gram-negative endotoxic shock. Cytokine 2006;34:161-9. (Pubitemid 44038571)
50. Yen D, Cheung J, Scheerens H, Poulet F, McClanahan T, McKenzie B, et al. IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6. J Clin Invest 2006;116:1310-6.
51. Sartor RB. Microbial influences in inflammatory bowel diseases. Gastroenterology 2008;134:577-94. (Pubitemid 351173057)
52. Onishi RM, Gaffen SL. Interleukin-17 and its target genes: mechanisms of interleukin-17 function in disease. Immunology 2010;129:311-21.
53. Zhou X, Chen Q, Moore J, Kolls JK, Halperin S, Wang J. Critical role of the interleukin-17/interleukin-17 receptor axis in regulating host susceptibility to respiratory infection with Chlamydia species. Infect Immun 2009;77:5059-70.
54. Bai H, Cheng J, Gao X, Joyee AG, Fan Y, Wang S, et al. IL-17/Th17 promotes type 1 T cell immunity against pulmonary intracellular bacterial infection through modulating dendritic cell function. J Immunol 2009;183:5886-95.
55. Schneider DF, Palmer JL, Tulley JM, Speicher JT, Kovacs EJ, Gamelli RL, et al. A novel role for NKT cells in cutaneous wound repair. J Surg Res 2011;168:325-33.
56. Maudsdotter L, Jonsson H, Roos S, Jonsson AB. Lactobacilli reduce cell cytotoxicity caused by Streptococcus pyogenes by producing lactic acid that degrades the toxic component lipoteichoic acid. Antimicrob Agents Chemother 2011;55:1622-8.
57. Armstrong L,Medford AR, Uppington KM, Robertson J,Witherden IR, Tetley TD, et al. Expression of functional Toll-like receptor-2 and -4 on alveolar epithelial cells. Am J Respir Cell Mol Biol 2004;31:241-5. (Pubitemid 39095455)
58. Blum S, Haller D, Pfeifer A, Schiffrin EJ. Probiotics and immune response. Clin Rev Allergy Immunol 2002;22:287-309. (Pubitemid 34521598)